scispace - formally typeset
C

Christopher J. Bohlen

Researcher at Genentech

Publications -  7
Citations -  4658

Christopher J. Bohlen is an academic researcher from Genentech. The author has contributed to research in topics: Neurodegeneration & Microglia. The author has an hindex of 5, co-authored 5 publications receiving 2822 citations. Previous affiliations of Christopher J. Bohlen include University of Melbourne.

Papers
More filters
Journal ArticleDOI

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology

TL;DR: Trem2 deficiency in the pR5-183 mouse model expressing mutant tau alone or in TauPS2APP mice, in which β-amyloid pathology exacerbates tau pathology and neurodegeneration, was examined in this paper.
Journal ArticleDOI

Microglia in Brain Development, Homeostasis, and Neurodegeneration

TL;DR: Recent genetic evidence for microglial involvement in neurodegenerative disease with a focus on Alzheimer disease is summarized, aiming to synthesize varied aspects of microglian biology and highlight microglia as possible targets for therapeutic interventions in neuro degenerative disease.
Journal ArticleDOI

Isolation and Culture of Microglia.

TL;DR: Approaches for purification of microglia by fluorescence‐activated cell sorting using microgla‐specific surface markers and for enrichment of microGlia by magnetic sorting and immunopanning are described.
Journal ArticleDOI

Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9

TL;DR: Highly efficient gene editing in primary myeloid cells is made possible by optimized non-viral delivery of CRISPR-Cas9, which enables single and multiplexed gene knockout in monocytes, macrophages, and dendritic cells to advance innate immunity research and cell therapy.